Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.400
+0.120 (9.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Apyx Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 28.01 | 43.65 | 10.19 | 30.87 | 41.92 | 58.81 | Upgrade
|
Cash & Short-Term Investments | 28.01 | 43.65 | 10.19 | 30.87 | 41.92 | 58.81 | Upgrade
|
Cash Growth | 26.56% | 328.30% | -66.98% | -26.35% | -28.73% | -24.86% | Upgrade
|
Accounts Receivable | 13.04 | 14.12 | 10.7 | 13.14 | 8.4 | 7.99 | Upgrade
|
Other Receivables | - | 0.03 | 7.64 | 8.13 | 8.93 | 1.66 | Upgrade
|
Receivables | 13.04 | 14.15 | 18.35 | 21.26 | 17.33 | 9.65 | Upgrade
|
Inventory | 9 | 9.92 | 11.8 | 6.78 | 4.05 | 5.07 | Upgrade
|
Prepaid Expenses | 2.11 | 2.63 | 2.64 | 1.83 | 2.8 | 3.21 | Upgrade
|
Total Current Assets | 52.16 | 70.36 | 42.97 | 60.74 | 66.09 | 76.73 | Upgrade
|
Property, Plant & Equipment | 6.78 | 7.15 | 7.59 | 6.87 | 7.22 | 7.62 | Upgrade
|
Other Long-Term Assets | 1.79 | 1.73 | 1.22 | 1.11 | 0.81 | 0.39 | Upgrade
|
Total Assets | 60.72 | 79.24 | 51.78 | 68.72 | 74.11 | 84.75 | Upgrade
|
Accounts Payable | 1.91 | 2.71 | 2.67 | 2.63 | 1.51 | 2.44 | Upgrade
|
Accrued Expenses | 3.3 | 5.21 | 3.78 | 6.69 | 4.69 | 6.28 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 0.14 | Upgrade
|
Current Portion of Leases | 0.35 | 0.37 | 0.25 | 0.29 | 0.36 | 0.34 | Upgrade
|
Current Unearned Revenue | 0.5 | 0.49 | 0.85 | 0.53 | - | - | Upgrade
|
Other Current Liabilities | 3.49 | 3.97 | 4.3 | 3.07 | 2.59 | 3.11 | Upgrade
|
Total Current Liabilities | 9.56 | 12.74 | 11.85 | 13.21 | 9.15 | 12.31 | Upgrade
|
Long-Term Debt | 33.85 | 33.19 | - | - | - | - | Upgrade
|
Long-Term Leases | 4.64 | 4.95 | 0.54 | 0.02 | 0.31 | 0.66 | Upgrade
|
Long-Term Unearned Revenue | 1.27 | 1.25 | 1.41 | 1.32 | 0.62 | 0.41 | Upgrade
|
Other Long-Term Liabilities | 0.2 | 0.2 | 0.18 | 0.17 | 0.17 | 0.11 | Upgrade
|
Total Liabilities | 49.52 | 52.32 | 13.98 | 14.71 | 10.25 | 13.49 | Upgrade
|
Common Stock | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 84.29 | 81.11 | 73.28 | 66.22 | 61.07 | 56.71 | Upgrade
|
Retained Earnings | -73.28 | -54.45 | -35.74 | -12.55 | 2.62 | 14.52 | Upgrade
|
Total Common Equity | 11.04 | 26.7 | 37.58 | 53.7 | 63.72 | 71.26 | Upgrade
|
Minority Interest | 0.16 | 0.22 | 0.21 | 0.31 | 0.14 | - | Upgrade
|
Shareholders' Equity | 11.2 | 26.92 | 37.79 | 54.01 | 63.86 | 71.26 | Upgrade
|
Total Liabilities & Equity | 60.72 | 79.24 | 51.78 | 68.72 | 74.11 | 84.75 | Upgrade
|
Total Debt | 38.85 | 38.5 | 0.8 | 0.31 | 0.68 | 1.13 | Upgrade
|
Net Cash (Debt) | -10.83 | 5.15 | 9.4 | 30.57 | 41.24 | 57.68 | Upgrade
|
Net Cash Growth | - | -45.18% | -69.26% | -25.88% | -28.50% | -26.18% | Upgrade
|
Net Cash Per Share | -0.31 | 0.15 | 0.27 | 0.89 | 1.21 | 1.69 | Upgrade
|
Filing Date Shares Outstanding | 34.64 | 34.64 | 34.6 | 34.43 | 34.32 | 34.17 | Upgrade
|
Total Common Shares Outstanding | 34.64 | 34.64 | 34.6 | 34.41 | 34.29 | 34.17 | Upgrade
|
Working Capital | 42.6 | 57.62 | 31.12 | 47.53 | 56.94 | 64.42 | Upgrade
|
Book Value Per Share | 0.32 | 0.77 | 1.09 | 1.56 | 1.86 | 2.09 | Upgrade
|
Tangible Book Value | 11.04 | 26.7 | 37.58 | 53.7 | 63.72 | 71.26 | Upgrade
|
Tangible Book Value Per Share | 0.32 | 0.77 | 1.09 | 1.56 | 1.86 | 2.09 | Upgrade
|
Land | - | - | 1.6 | 1.6 | 1.6 | 1.6 | Upgrade
|
Buildings | - | - | 4.43 | 4.43 | 4.45 | 4.42 | Upgrade
|
Machinery | - | 4.83 | 5.09 | 5.04 | 4.72 | 4.69 | Upgrade
|
Construction In Progress | - | 0.4 | 0.51 | 0.65 | 0.42 | 0.15 | Upgrade
|
Leasehold Improvements | - | 0.21 | 0.18 | 0.17 | 0.16 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.